Lamivudine plus adefovir is a good option for chronic hepatitis B patients with viral relapse after cessation of lamivudine treatment

AIM: Currently, there is no consensus on the retreatment recommendation of chronic hepatitis B (CHB) patients with viral rebound after cessation of treatment. In the search of reasonable treatment, we compared the efficacy and safety of adefovir (ADV) plus lamivudine (LAM) and LAM alone for the retr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wang, Zhao, Wu, Xiao-Ling, Zeng, Wei-Zheng, Xu, Hui, Zhang, Yong, Qin, Jian-Ping, Jiang, Ming-De
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2011
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3162546/
https://ncbi.nlm.nih.gov/pubmed/21816062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-422X-8-388
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados